Intuitive Surgical, Inc. $ISRG Stock Position Cut by CI Investments Inc.

CI Investments Inc. decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 125,116 shares of the medical equipment provider’s stock after selling 61,937 shares during the period. CI Investments Inc.’s holdings in Intuitive Surgical were worth $57,677,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Newbridge Financial Services Group Inc. boosted its holdings in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares in the last quarter. Olistico Wealth LLC bought a new stake in Intuitive Surgical during the fourth quarter worth approximately $28,000. Main Street Group LTD acquired a new stake in Intuitive Surgical in the first quarter worth approximately $30,000. Laurel Wealth Advisors LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth approximately $31,000. Finally, Vermillion Wealth Management Inc. boosted its stake in Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the transaction, the director owned 120 shares in the company, valued at approximately $55,620. This trade represents a 49.79% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock worth $3,059,135 over the last ninety days. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Recent commentary highlights that Intuitive Surgical’s latest earnings were impressive, with the company continuing to post strong growth and beating expectations, which supports the long-term investment case. Article Title
• Positive Sentiment: Analysts and recent coverage argue the stock may be oversold, with Wall Street estimate revisions moving higher and some writers saying the pullback could create a buying opportunity for growth investors. Article Title
• Positive Sentiment: One valuation-focused piece says ISRG is being priced for slower growth than it is currently delivering, suggesting the stock could be undervalued if the company maintains its current pace. Article Title
• Neutral Sentiment: Multiple articles note that ISRG has become a heavily watched and widely discussed stock, reflecting heightened investor attention rather than a clear new business catalyst. Article Title
• Negative Sentiment: Despite the strong fundamentals, the stock has fallen sharply over the past several weeks, and several reports frame the decline as a correction driven by investor caution around valuation and recent price weakness. Article Title

Wall Street Analyst Weigh In

ISRG has been the topic of several research analyst reports. Truist Financial lowered their price target on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research report on Thursday, July 16th. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a report on Thursday, April 23rd. JPMorgan Chase & Co. decreased their target price on Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research note on Friday, July 17th. TD Cowen lowered their target price on Intuitive Surgical from $585.00 to $520.00 and set a “buy” rating on the stock in a report on Monday, July 13th. Finally, BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a research report on Monday. Twenty-one analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $523.46.

Intuitive Surgical Stock Down 0.9%

ISRG opened at $350.06 on Wednesday. Intuitive Surgical, Inc. has a 12-month low of $342.10 and a 12-month high of $603.88. The firm has a market capitalization of $123.98 billion, a P/E ratio of 40.10, a PEG ratio of 2.72 and a beta of 1.46. The stock has a fifty day moving average of $412.30 and a 200-day moving average of $464.06.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 17.09%. Intuitive Surgical’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.81 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 8.61 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.